What’s Going On With Micron Stock After Hours?

Micron Technology Inc (NASDAQ: MU) reported fiscal second-quarter financial results after the bell.

Micron Technology Inc (NASDAQ:MU) reported fiscal second-quarter financial results after the bell. The stock is reacting favorably to the print even though the numbers came in weaker than expected. 

What Happened: Micron reported second-quarter revenue of $3.69 billion, down from $7.79 billion year-over-year and below consensus estimates of $3.72 billion, according to Benzinga Pro. 

The chip company reported a quarterly loss of $1.91 per share, which missed estimates for a loss of 81 cents per share. Micron said inventory write-downs totaled $1.43 billion, which had a $1.34 per share impact on earnings.

Operating cash flow came in at $343 million, down from $3.63 billion on a year-over-year basis.

“Micron delivered fiscal second-quarter revenue within our guidance range in a challenging market environment. Customer inventories are getting better, and we expect gradual improvements to the industry’s supply-demand balance,” said Sanjay Mehrotra, president and CEO of Micron.

Micron sees fiscal third-quarter revenue of $3.7 billion, plus or minus $200 million, versus estimates of $3.7 billion. The company anticipates a quarterly loss of $1.58 per share, plus or minus 7 cents per share.

The company will hold a conference call to discuss these results at 4:30 p.m. ET.

MU Price Action: Micron has a 52-week high of $86.23 and a 52-week low of $48.43. 

The stock was up 1.96% after hours at $60.44 at the time of publication, according to Benzinga Pro.

Photo: courtesy of Micron.

Total
0
Shares
Related Posts
Read More

Abbott Unveils Late-Breaking Data Showing The World’s First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Safety And Performance Endpoints; To Present On May 19-21 At The Heart Rythm Society Annual Meeting

Abbott's AVEIR™ DR i2i™ IDE study is the industry's first prospective study on the safety and performance of the world's first dual-chamber leadless pacemakerThe study successfully met all three of its

ABT